Am I too late to buy CRL?

Charles River Laboratories International, Inc. (CRL): Yes, too late. We wouldn't buy it here.

Verdict as of .

Our model puts the odds of CRL being higher in three months at 28% (worse than a coin flip), and its three-month estimate is $278.34, 4.6% below today's $291.76. Buying now means paying more than we think it will be worth, so we wouldn't start a position at this price: a missed trade costs nothing, this one can.

Where we'd be wrong: We're wrong if CRL closes above $326.91 within three months, the top of our 90% forecast band. Above that our model under-called the move: our call failed, and we withdraw it.

The prices behind this verdict

Why: the risk checks behind the call

Related pages:

Educational research only — not investment advice.